{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:50:30Z","timestamp":1718585430819},"reference-count":49,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8,1]]},"abstract":"<jats:p>Haemolytic uraemic syndrome (HUS) is the major complication of Escherichia coli gastrointestinal infections that are Shiga toxin (Stx) producing. Monocytes contribute to HUS evolution by producing cytokines that sensitize endothelial cells to Stx action and migration to the injured kidney. As CC chemokine receptors (CCRs) are involved in monocyte recruitment to injured tissue, we analysed the contribution of these receptors to the pathogenesis of HUS. We analysed CCR1, CCR2 and CCR5 expression in peripheral monocytes from HUS patients during the acute period, with healthy children as controls. We observed an increased expression of CCRs per cell in monocytes from HUS patients, accompanied by an increase in the absolute number of monocytes CCR1+, CCR2+ and CCR5+. It is interesting that prospective analysis confirmed that CCR1 expression positively correlated with HUS severity. The evaluation of chemokine levels in plasma showed that regulated on activation of normal T-cell-expressed and -secreted (RANTES) protein was reduced in plasma from patients with severe HUS, and this decrease correlated with thrombocytopenia. Finally, the expression of the higher CCRs was accompanied by a loss of functionality which could be due to a mechanism for desensitization to compensate for altered receptor expression. The increase in CCR expression correlates with HUS severity, suggesting that the dysregulation of these receptors might contribute to an increased risk of renal damage. Activated monocytes could be recruited by chemokines and then receptors could be dysregulated. The dysregulation of CCRs and their ligands observed during the acute period suggests that a chemokine pathway would participate in HUS development.<\/jats:p>","DOI":"10.1042\/cs20150016","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T10:07:23Z","timestamp":1425982043000},"page":"235-244","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes"],"prefix":"10.1042","volume":"129","author":[{"given":"Maria Victoria","family":"Ramos","sequence":"first","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matias","family":"Ruggieri","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Analia Cecilia","family":"Panek","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pilar","family":"Mejias","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina Jimena","family":"Fernandez-Brando","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jimena","family":"Abrey-Recalde","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Exeni","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda, Hospital Municipal del Ni\u00f1o, San Justo, Provincia de Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Barilari","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda, Hospital Municipal del Ni\u00f1o, San Justo, Provincia de Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Exeni","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda, Hospital Municipal del Ni\u00f1o, San Justo, Provincia de Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Sandra","family":"Palermo","sequence":"additional","affiliation":[{"name":"Laboratorio de Patog\u00e9nesis e Inmunolog\u00eda de Procesos Infecciosos, Instituto de Medicina Experimental Medicine (IMEX-CONICET), Academia Nacional de Medicina, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2015,5,8]]},"reference":[{"key":"2021113010383184400_B1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.11.3.450","article-title":"Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections","volume":"11","author":"Paton","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"2021113010383184400_B2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ki.1995.261","article-title":"The hemolytic uremic syndrome","volume":"48","author":"Remuzzi","year":"1995","journal-title":"Kidney Int."},{"key":"2021113010383184400_B3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2005-08-3219","article-title":"Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome","volume":"108","author":"Stahl","year":"2006","journal-title":"Blood"},{"key":"2021113010383184400_B4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1128\/IAI.73.1.403-412.2005","article-title":"Chemokine expression in the monocytic cell line THP-1\u00a0in response to purified shiga toxin 1 and\/or lipopolysaccharides","volume":"73","author":"Harrison","year":"2005","journal-title":"Infect. Immun."},{"key":"2021113010383184400_B5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH05-02-0115","article-title":"Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function","volume":"94","author":"Guessous","year":"2005","journal-title":"Thromb. Haemost."},{"key":"2021113010383184400_B6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ki.1997.170","article-title":"Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells","volume":"51","author":"van Setten","year":"1997","journal-title":"Kidney Int."},{"key":"2021113010383184400_B7","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.4049\/jimmunol.154.8.4099","article-title":"The adhesion molecules used by monocytes for migration across endothelium include CD11a\/CD18, CD11b\/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium","volume":"154","author":"Meerschaert","year":"1995","journal-title":"J. Immunol."},{"key":"2021113010383184400_B8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0171-2985(11)80453-5","article-title":"Adhesion molecules mediating recruitment of monocytes to inflamed tissue","volume":"191","author":"Patarroyo","year":"1994","journal-title":"Immunobiology"},{"key":"2021113010383184400_B9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0065-2776(08)60509-X","article-title":"Interleukin-8 and related chemotactic cytokines\u2013CXC and CC chemokines","volume":"55","author":"Baggiolini","year":"1994","journal-title":"Adv. Immunol."},{"key":"2021113010383184400_B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000058734","article-title":"Chemokines. Introduction and overview","volume":"72","author":"Mantovani","year":"1999","journal-title":"Chem. Immunol."},{"key":"2021113010383184400_B11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1523-1755.2003.00750.x","article-title":"Chemokines and chemokine receptors are involved in the resolution or progression of renal disease","volume":"63","author":"Anders","year":"2003","journal-title":"Kidney Int."},{"key":"2021113010383184400_B12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1046\/j.1523-1755.1998.00118.x","article-title":"Shiga toxin-1 regulation of cytokine production by human proximal tubule cells","volume":"54","author":"Hughes","year":"1998","journal-title":"Kidney Int."},{"key":"2021113010383184400_B13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1086\/515592","article-title":"Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2","volume":"178","author":"Kiyokawa","year":"1998","journal-title":"J. Infect. Dis."},{"key":"2021113010383184400_B14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1128\/IAI.01663-06","article-title":"Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome","volume":"75","author":"Keepers","year":"2007","journal-title":"Infect. Immun."},{"key":"2021113010383184400_B15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ajpath.2011.11.011","article-title":"Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome","volume":"180","author":"Ramos","year":"2012","journal-title":"Am. J. Pathol."},{"key":"2021113010383184400_B16","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1182\/blood-2006-06-026997","article-title":"Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"key":"2021113010383184400_B17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4049\/jimmunol.181.2.1460","article-title":"Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin","volume":"181","author":"Zanchi","year":"2008","journal-title":"J. Immunol."},{"key":"2021113010383184400_B18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2353\/ajpath.2007.060366","article-title":"CXCL1\/KC and CXCL2\/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation","volume":"170","author":"Roche","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2021113010383184400_B19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000180229","article-title":"The hemolytic-uremic syndrome","volume":"11","author":"Gianantonio","year":"1973","journal-title":"Nephron"},{"key":"2021113010383184400_B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-1759(81)90074-0","article-title":"Isolation of human monocytes on re-orienting gradients of Percoll","volume":"40","author":"Hardin","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"2021113010383184400_B21","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.4049\/jimmunol.170.6.3273","article-title":"Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis","volume":"170","author":"Maus","year":"2003","journal-title":"J. Immunol."},{"key":"2021113010383184400_B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol."},{"key":"2021113010383184400_B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"key":"2021113010383184400_B24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14 +CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"2021113010383184400_B25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.imlet.2013.03.004","article-title":"Sources of heterogeneity in human monocyte subsets","volume":"152","author":"Appleby","year":"2013","journal-title":"Immunol. Lett."},{"key":"2021113010383184400_B26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1189\/jlb.0505251","article-title":"Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome","volume":"78","author":"Fernandez","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"2021113010383184400_B27","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4049\/jimmunol.148.8.2423","article-title":"Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes","volume":"148","author":"Jiang","year":"1992","journal-title":"J. Immunol."},{"key":"2021113010383184400_B28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1203\/00006450-200212000-00019","article-title":"Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome","volume":"52","author":"Proulx","year":"2002","journal-title":"Pediatr. Res."},{"key":"2021113010383184400_B29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s004670050712","article-title":"Circulating inflammatory cytokine levels in hemolytic uremic syndrome","volume":"13","author":"Litalien","year":"1999","journal-title":"Pediatr. Nephrol."},{"key":"2021113010383184400_B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0272-6386(00)70297-6","article-title":"Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome","volume":"35","author":"Proulx","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010383184400_B31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/ajkd.2000.17612","article-title":"Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome","volume":"36","author":"Masri","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010383184400_B32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jlb.67.5.699","article-title":"Differential chemokine receptor expression and function in human monocyte subpopulations","volume":"67","author":"Weber","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"2021113010383184400_B33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/80819","article-title":"Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys","volume":"1","author":"D\u2019Amico","year":"2000","journal-title":"Nat. Immunol."},{"key":"2021113010383184400_B34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"2021113010383184400_B35","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/carcin\/bgu046","article-title":"A CCL2\/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma","volume":"35","author":"Li","year":"2014","journal-title":"Carcinogenesis"},{"key":"2021113010383184400_B36","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci. Signal."},{"key":"2021113010383184400_B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0741-8329(02)00200-8","article-title":"Neutrophil-mediated tissue injury in alcoholic hepatitis","volume":"27","author":"Jaeschke","year":"2002","journal-title":"Alcohol"},{"key":"2021113010383184400_B38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/sj.bjp.0704371","article-title":"Analysis of the temporal expression of chemokines and chemokine receptors during experimental granulomatous inflammation: role and expression of MIP-1alpha and MCP-1","volume":"134","author":"Carollo","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"2021113010383184400_B39","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2174\/157016110793563816","article-title":"Targeting the MCP-1\/CCR2 System in diabetic kidney disease","volume":"8","author":"Giunti","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"2021113010383184400_B40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1126\/science.7689250","article-title":"A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor","volume":"261","author":"Horuk","year":"1993","journal-title":"Science"},{"key":"2021113010383184400_B41","doi-asserted-by":"publisher","first-page":"32078","DOI":"10.1074\/jbc.272.51.32078","article-title":"Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6","volume":"272","author":"Nibbs","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021113010383184400_B42","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1084\/jem.181.4.1311","article-title":"The Duffy antigen\/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor","volume":"181","author":"Peiper","year":"1995","journal-title":"J. Exp. Med."},{"key":"2021113010383184400_B43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbrc.2004.06.146","article-title":"The human Duffy antigen binds selected inflammatory but not homeostatic chemokines","volume":"321","author":"Gardner","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010383184400_B44","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.4049\/jimmunol.170.5.2279","article-title":"Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6","volume":"170","author":"Fra","year":"2003","journal-title":"J. Immunol."},{"key":"2021113010383184400_B45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0002-9440(10)64035-7","article-title":"The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors","volume":"158","author":"Nibbs","year":"2001","journal-title":"Am. J. Pathol."},{"key":"2021113010383184400_B46","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/j.1538-7836.2012.04757.x","article-title":"Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura","volume":"10","author":"Feng","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"2021113010383184400_B47","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/506623","article-title":"Low levels of RANTES are associated with mortality in children with cerebral malaria","volume":"194","author":"John","year":"2006","journal-title":"J. Infect. Dis."},{"key":"2021113010383184400_B48","doi-asserted-by":"publisher","first-page":"e4261","DOI":"10.1371\/journal.pone.0004261","article-title":"IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity","volume":"4","author":"Ng","year":"2009","journal-title":"PLoS ONE"},{"key":"2021113010383184400_B49","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2141.2004.05350.x","article-title":"Significance of the CC chemokine RANTES in patients with haematological malignancy: results from a prospective observational study","volume":"128","author":"Ellis","year":"2005","journal-title":"Br. J. Haematol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/129\/3\/235\/443723\/cs1290235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/129\/3\/235\/443723\/cs1290235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T17:10:11Z","timestamp":1691514611000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/129\/3\/235\/71272\/Association-of-haemolytic-uraemic-syndrome-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,8]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20150016","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,8]]}}}